225 related articles for article (PubMed ID: 15183799)
1. Clinical and immunologic aspects of cancer-associated retinopathy.
Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
[TBL] [Abstract][Full Text] [Related]
2. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
Ohguro H; Ogawa K; Nakagawa T
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
4. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of photoreceptor cell death in cancer-associated retinopathy.
Maeda T; Maeda A; Maruyama I; Ogawa KI; Kuroki Y; Sahara H; Sato N; Ohguro H
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):705-12. PubMed ID: 11222531
[TBL] [Abstract][Full Text] [Related]
7. [Carcinoma-associated retinopathy: a review with clinical examples].
Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoma-associated retinopathy].
Ohguro H; Maruyama I
Ryoikibetsu Shokogun Shirizu; 2000; (31):73-6. PubMed ID: 11269192
[No Abstract] [Full Text] [Related]
9. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
Heckenlively JR; Fawzi AA; Oversier J; Jordan BL; Aptsiauri N
Arch Ophthalmol; 2000 Nov; 118(11):1525-33. PubMed ID: 11074809
[TBL] [Abstract][Full Text] [Related]
10. Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
Saito W; Kase S; Yoshida K; Ohguro H; Yokoi M; Iwaki H; Ohno S
Am J Ophthalmol; 2005 Nov; 140(5):942-5. PubMed ID: 16310487
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy.
Potter MJ; Thirkill CE; Dam OM; Lee AS; Milam AH
Ophthalmology; 1999 Nov; 106(11):2121-5. PubMed ID: 10571347
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.
Maeda A; Ohguro H; Maeda T; Wada I; Sato N; Kuroki Y; Nakagawa T
Cancer Res; 2000 Apr; 60(7):1914-20. PubMed ID: 10766180
[TBL] [Abstract][Full Text] [Related]
14. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic retinopathy and anti-recoverin antibodies].
Bataller L; Graus F; Dalmau J
Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
[No Abstract] [Full Text] [Related]
16. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
17. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
18. The cancer-associated retinopathy antigen is a recoverin-like protein.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated retinopathy vs recoverin-associated retinopathy.
Keltner JL; Thirkill CE
Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
[No Abstract] [Full Text] [Related]
20. [Paraneoplastic retinal degeneration, cancer-associated retinopathy].
Kuriyama M; Fujii A; Yoneda M
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):347-50. PubMed ID: 11031966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
